Summary for ARTG Entry:
Fresenius Kabi Australia Pty Limited - Ambix Intraport T Powerflow - Port, infusion, implantable
ARTG entry for
Medical Device Included Class III
Fresenius Kabi Australia Pty Ltd
Level 2, 2 Woodland Way,Mount Kuring-gai, NSW, 2080
ARTG Start Date
Medical Device Class III
- The inclusion of the kind of device in the ARTG is subject to compliance with all conditions placed or imposed on the ARTG entry. Refer Part 4-5,
Division 2 (Conditions) of the Therapeutic Goods Act 1989 and Part 5, Division 5.2 (Conditions) of the Therapeutic Goods (Medical Devices) Regulations
2002 for relevant information.
- Breaching conditions of the inclusion related to the device of the kind may lead to suspension or cancellation of the ARTG entry; may be a criminal
offence; and civil penalties may apply.
Fresenius Kabi AG
Bad Homburg, , D-61346
1. Ambix Intraport T Powerflow - Port, infusion, implantable
35911 Port, infusion, implantable
Completely implantable catheter system consisting of a titanium casing, a medicine compartment with a
silicone membrane and a polyurethane catheter which can be connected to the port casing.
Indicated when treatments require long-term, repeated access to the venous vascular system. Medicines,
intravenous infusions, parenteral nutrition or blood products, for example, can be applied via the venous
port systems. Also suitable for blood sampling purposes and high-pressure injection/infusion.
Nil variant (as 1 device) -
No Specific Conditions included on Record
© Commonwealth of Australia.This work is copyright.You are not permitted to re-transmit, distribute or commercialise the material without obtaining prior
written approval from the Commonwealth.Further details can be found at http://www.tga.gov.au/about/website-copyright.htm.
Page 1 of
Produced at 02.12.2017 at 04:12:31 AEDT
This is not an ARTG Certificate document.
The onus is on the reader to verify the current accuracy of the information on the document subsequent to the date shown.
Visit www.tga.gov.au for contact information